AI
Tuesday, October 10, 2017 8:36:45 AM
CVM - 1.69 Pre-market now at 2.01/2.02 and moving.
CEL-SCI Granted European Patent for Multikine's Mechanism of Action in Making Tumors 'Visible' to the Immune System
CEL-SCI Granted European Patent for Multikine's Mechanism of Action in Making Tumors 'Visible' to the Immune System
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
